US Patent Issued to Juno Therapeutics on May 20 for "Immunomodulatory polypeptides and related compositions and methods" (Washington Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,935, issued on May 20, was assigned to Juno Therapeutics Inc. (Seattle).

"Immunomodulatory polypeptides and related compositions and methods" was invented by Collin Hauskins (Seattle) and Allen Ebens (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are immunomodulatory polypeptides containing first and second submits of a cytokine or a chemokine connected by a joining region containing a targeting moiety that binds to a target molecule. In some aspects, the disclosure further relates to engineered cells and compositions comprising the immunomodulatory polypeptides and methods for their administration to subjects. In some embod...